Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I One-Month Safety, Pharmacokinetic, Pharmacodynamic, and Acceptability Study of Intravaginal Rings Releasing Tenofovir and Levonorgestrel or Tenofovir Alone

NCT02235662 is registered in ClinicalTrials.gov with CONRAD as lead sponsor.

NCT NCT02235662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02235662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I One-Month Safety, Pharmacokinetic, Pharmacodynamic, and Acceptability Study of Intravaginal Rings Releasing Tenofovir and Levonorgestrel or Tenofovir Alone
Lead sponsor
CONRAD
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2014
Completion date
December 31, 2015
Enrollment
86 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

contraception, hiv